Rie Sugimoto

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Chigusa Morizane, Takuji Okusaka, Junki Mizusawa et al. · Annals of Oncology · 2019 · 334 citations

Medicine, Oncology, Chemotherapy +7

Cloning and Characterization of the Hakata Antigen, a Member of the Ficolin/Opsonin p35 Lectin Family

Rie Sugimoto, Yoshiaki Yae, Mina Akaiwa et al. · Journal of Biological Chemistry · 1998 · 211 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

M. Ikeda, Satoshi Shimizu, Tosiya Sato et al. · Annals of Oncology · 2016 · 170 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Activation of Retinoic X Receptor and Peroxisome Proliferator-Activated Receptor–γ Inhibits Nitric Oxide and Tumor Necrosis Factor–α Production in Rat Kupffer Cells

Koutaro Uchimura, Makoto Nakamuta, Munechika Enjoji et al. · Hepatology · 2001 · 127 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Hakata Antigen, a New Member of the Ficolin/Opsonin p35 Family, Is a Novel Human Lectin Secreted into Bronchus/Alveolus and Bile

Mina Akaiwa, Yoshiaki Yae, Rie Sugimoto et al. · Journal of Histochemistry & Cytochemistry · 1999 · 120 citations

Life Sciences, Biochemistry, Immunology +10